Subject: What's the Plan When They Close Down all the Research Peptides?
From: Ginger Lichlyter <[email-masked]>
To: TJ Bourdeau <[email-masked]>
Date: Thu, 19 Mar 2026 19:26:13 +0000 (UTC)

Hi Again,

Hey there, Quick question… Are you actually confident in what you’re doing right now… or are you piecing things together and hoping it works? Because tonight, we fix that. At 7PM Central tonight, I’m hosting a live Q&A inside Total Well Connect — and I’m pulling back the curtain on everything people keep asking me about: • How to actually use the peptide calculator (without second guessing yourself) • Reconstitution made simple (no confusion, no overthinking) • Stacking — what people are doing and what’s actually working • What to do when you hit a stall and nothing is moving • And… the new pharmacy rollout using 503B / 503A (same pricing structure people are used to… but a completely different level of access) This is not a surface-level call. This is where things start to click. No recordings. No replay. If you’re there, you’re in the room. Spots are limited, so grab your seat here: https://us02web.zoom.us/meeting/register/ivrcLO9MScS6uEnYKr0fPg If you’ve been waiting for clarity… this is it.

Click on the link below to open the message in a browser:
https://gingerlichlyter202.wixsite.com/so/89Pq7Z3zF/c?w=higIgQLCaYxYyFZDKumGpOfUk-q_Kt5AlJHYmMRVMr8.eyJ1IjoiaHR0cHM6Ly9naW5nZXJsaWNobHl0ZXIyMDIud2l4c2l0ZS5jb20vc28vODlQcTdaM3pGP2xhbmd1YWdlVGFnPWVuIiwibSI6Im1haWwiLCJjIjoiNzQ4NGIzZmQtOTM3NS00ZTIxLTkwNjYtY2E0NDFmN2NjNzcyIn0

You've received this email because you are a subscriber of this site.
https://gingerlichlyter202.wixsite.com/the-peptide-communit

If you feel you received it by mistake or wish to unsubscribe, please click here.
https://subscriptions.wixapps.net/_manage-consent/api/revoke-consent/unsubscribe?wixToken=JWE.eyJhbGciOiJBMTI4S1ciLCJlbmMiOiJBMTI4Q0JDLUhTMjU2Iiwia2lkIjoiZkhJbFA4M1cifQ.STj2kpX1NAqCwuVfCzi0WvCxzgrOusFJpwxALE0lajZVCeYe6TOZCw.CdCic1wlC-TfHZrg8iN82g.f4Hg97HrraTOx0UrC05ImSWeIP15g14893vNmpBDPiz6NNrAujdQezf84Q_UKXGrbMyAn9VXtQBPL-VtZ4hiUuq8SZPseb2NF4kWnM6pEir88XgCzNPLyU8hweWSWDkk_uWhVyww7DAuDnJSKuWqs7-Z17fXEUBMxqmIDBwQ-8pyRBsyFKyeMF-NlWU-ZOnrhX8zqSLLe0FgC5HKNjNA6HnkYyMOlBfqVgqbK6KK0UE4PHZM7DIhBBr1JX23YgkzkS3i3qiXjssUZda933f1aRzFx7mJdUaM9eREyFf9o_5JqmR4lVS2vw-TTktk63aZqm2zJNEcMBEARsE_79d0bU-e6bI-ORHNpPW7nXNXq-LnT5GcRE-uIe_Zc5HXzVUbY_B4TWPfSiUkLBfASeo7F1ftBvLv0-bXIV0Sv0ZGul0-UkyIdD5Ogm2WJ8QVN5yl.Nen07r1b5yzbyfn7kqMn6g&locale=en